Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations 2014 is a webinar that covers topics such as:
- General requirements to register a biosimilar product
- Introduction - biosimilars
- Requirements for comparability data
- Regulatory considerations in emerging markets
- Overview of key emerging markets
Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations 2014 brings together:
- Senior management executives (CEO, COO, CFO, etc)
- Regulatory affairs professionals
- Intellectual property experts
- Drug discovery and development professionals (R&D and CMC)
- Regulatory Compliance Associates and Managers
- Project Managers and Clinical trial specialists
- People investing in FDA-regulated product development projects
